Volvick Derose

Array ( [id] => 903323 [patent_doc_number] => 07335643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Compositions of active Wnt protein' [patent_app_type] => utility [patent_app_number] => 11/595357 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 15 [patent_no_of_words] => 10983 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335643.pdf [firstpage_image] =>[orig_patent_app_number] => 11595357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602894 [patent_doc_number] => 20060293239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Treatment and Diagnosis of Insulin-Resistant States' [patent_app_type] => utility [patent_app_number] => 11/465956 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19494 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293239.pdf [firstpage_image] =>[orig_patent_app_number] => 11465956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5666641 [patent_doc_number] => 20060171991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Method for stromal corneal repair and refractive alteration' [patent_app_type] => utility [patent_app_number] => 11/386543 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5501 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171991.pdf [firstpage_image] =>[orig_patent_app_number] => 11386543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743163 [patent_doc_number] => 20060088888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Methods of identifying inhibitors of GADD45 polypeptide activity, and inhibitors of such activity' [patent_app_type] => utility [patent_app_number] => 11/297160 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23421 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088888.pdf [firstpage_image] =>[orig_patent_app_number] => 11297160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5812973 [patent_doc_number] => 20060083689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Contrast enhancement agent for magnetic resonance imaging' [patent_app_type] => utility [patent_app_number] => 11/294625 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18639 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20060083689.pdf [firstpage_image] =>[orig_patent_app_number] => 11294625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535108 [patent_doc_number] => 07173009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Surfactant protein C esters' [patent_app_type] => utility [patent_app_number] => 11/287197 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5335 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/173/07173009.pdf [firstpage_image] =>[orig_patent_app_number] => 11287197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 556504 [patent_doc_number] => 07160984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-09 [patent_title] => 'Process for preparing glycopeptide derivatives' [patent_app_type] => utility [patent_app_number] => 11/268913 [patent_app_country] => US [patent_app_date] => 2005-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4594 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/160/07160984.pdf [firstpage_image] =>[orig_patent_app_number] => 11268913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638043 [patent_doc_number] => 20060069017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Somatostatin analog and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/269073 [patent_app_country] => US [patent_app_date] => 2005-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7115 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069017.pdf [firstpage_image] =>[orig_patent_app_number] => 11269073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 475319 [patent_doc_number] => 07226910 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-05 [patent_title] => 'Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists' [patent_app_type] => utility [patent_app_number] => 11/262067 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15532 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/226/07226910.pdf [firstpage_image] =>[orig_patent_app_number] => 11262067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 453414 [patent_doc_number] => 07247701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => 'Amino amides, peptides and peptidomimetics' [patent_app_type] => utility [patent_app_number] => 11/227986 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8622 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247701.pdf [firstpage_image] =>[orig_patent_app_number] => 11227986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591416 [patent_doc_number] => 20060040868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Methods for treating premature infants' [patent_app_type] => utility [patent_app_number] => 11/200112 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7001 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040868.pdf [firstpage_image] =>[orig_patent_app_number] => 11200112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 690784 [patent_doc_number] => 07074758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Two gonadotropin releasing hormones and a method to isolate the same' [patent_app_type] => utility [patent_app_number] => 11/148067 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3897 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 318 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074758.pdf [firstpage_image] =>[orig_patent_app_number] => 11148067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591418 [patent_doc_number] => 20060040870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Enhancement of apoptosis by caspase-9 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/139941 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8120 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040870.pdf [firstpage_image] =>[orig_patent_app_number] => 11139941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 531599 [patent_doc_number] => 07179789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-20 [patent_title] => 'Compositions and methods for treatment of rosacea' [patent_app_type] => utility [patent_app_number] => 11/123823 [patent_app_country] => US [patent_app_date] => 2005-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6980 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179789.pdf [firstpage_image] =>[orig_patent_app_number] => 11123823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 522156 [patent_doc_number] => 07186687 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-06 [patent_title] => 'Compositions and methods for treatment of Psoriasis' [patent_app_type] => utility [patent_app_number] => 11/123543 [patent_app_country] => US [patent_app_date] => 2005-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7586 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186687.pdf [firstpage_image] =>[orig_patent_app_number] => 11123543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005127 [patent_doc_number] => 20050170440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Treatment and diagnosis of insulin-resistant states' [patent_app_type] => utility [patent_app_number] => 11/056562 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19485 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20050170440.pdf [firstpage_image] =>[orig_patent_app_number] => 11056562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 468889 [patent_doc_number] => 07232804 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-19 [patent_title] => 'Use of KPV tripeptide for dermatological disorders' [patent_app_type] => utility [patent_app_number] => 11/049063 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5028 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/232/07232804.pdf [firstpage_image] =>[orig_patent_app_number] => 11049063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7196186 [patent_doc_number] => 20050164277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Novel human hemicentin proteins and polynucleotides encoding the same' [patent_app_type] => utility [patent_app_number] => 11/049637 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8822 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164277.pdf [firstpage_image] =>[orig_patent_app_number] => 11049637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5747449 [patent_doc_number] => 20060110380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Compositions for inhibiting thrombin-induced coagulation and methods of use' [patent_app_type] => utility [patent_app_number] => 11/010406 [patent_app_country] => US [patent_app_date] => 2004-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12071 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110380.pdf [firstpage_image] =>[orig_patent_app_number] => 11010406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051256 [patent_doc_number] => 20050187143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Zinc-free and low-zinc insulin preparations having improved stability' [patent_app_type] => utility [patent_app_number] => 11/007155 [patent_app_country] => US [patent_app_date] => 2004-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5798 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187143.pdf [firstpage_image] =>[orig_patent_app_number] => 11007155 [rel_patent_id] =>[rel_patent_doc_number] =>)